Core Insights - AMT Medical has developed the ELANA seamless heart bypass technology, allowing surgeries without chest opening, thus reducing patient trauma and recovery time [1][4][16] Industry Overview - Cardiovascular diseases (CVDs) remain a leading cause of death globally, with approximately 18.5 million deaths in 2023, projected to rise to 24 million by 2030 [2] - Traditional coronary artery bypass grafting (CABG) surgeries face significant challenges, including chest trauma, recovery difficulties, and high medical costs [2][3] Technology Advantages - The ELANA system utilizes laser-assisted vascular connections and specialized clips, enabling surgeries without sutures and heart-lung machines, thus maintaining blood circulation during procedures [4][5][7] - The system significantly reduces stroke risk from 3%-5% in traditional surgeries to less than 1% with ELANA, and lowers anastomosis leak rates from 8%-12% to below 2% [9][10] Market Potential - The global minimally invasive surgery market is projected to grow from $62 billion in 2023 to $130 billion by 2030, with cardiovascular devices accounting for over 30% of this market [3] - AMT's technology is adaptable for various surgical methods and has potential applications in peripheral vascular bypass and heart valve repair, expanding its market reach [10][15] Financial Backing - AMT has raised a total of €24.5 million (approximately $26 million) in funding, including a recent €22 million Series B round to accelerate CE certification and clinical trials in the U.S. [11][12][13] Future Plans - The company aims to achieve CE certification by 2026 and initiate FDA approval processes in 2027, targeting to reduce surgical costs by an additional 30% and benefit one million patients annually [15][16]

速览投资风口，掌握资本律动。 将投中网设为"星标⭐"，第一时间收获最新推送 作者丨簪竹 来源丨投中网 大家好，我是长风。今天给大家带来上周资本市场的专业投研信息。 上周焦点回顾： 机器人赛道，知名VC齐聚。 人形机器人公司松延动力完成连续两轮过亿元A轮及A+轮融资。A+轮 由彬复领投，华强资本跟投；A轮投资方包括神骐资本、北京未来科学城基金、天启资本、泽然资 本、教育科技集团战略方等机构。此外，机器人产品公司——维他动力宣布完成种子+轮融资。自成 立至今的三个月内，已累计完成2亿元种子轮融资。本轮融资由凯辉基金和今日资本联合领投，雅瑞 资本参与投资，高瓴创投、元璟资本、初心资本、柏睿资本及BV百度风投等多家首轮投资方持续跟 投。 大健康赛道，微创器械受关注。 上周，合肥易联立通医疗科技有限公司近日完成种子轮融资，由合 肥产投国正投资与合肥包河创投联合投资。同一天，微创手术器械供应商普瑞顺祥也宣布已完成数千 万元A轮融资。本轮融资由亦庄国投投资。 AI赛道，明星企业纷纷融资。 3月19日，成都高新区宣布向智谱注资3亿元。这是智谱本月内的第三 次融资了。一个月不到融三轮，总计拿下18亿元。与此同时，AI for ...